Removal of aprotinin from low-dose aprotinin/tranexamic acid antifibrinolytic therapy increases transfusion requirements in cardiothoracic surgery

A.B.A. Vonk, M.I. Meesters, J. Schats, J.W.A. Romijn, E.K. Jansen, C. Boer

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)135-139
JournalInteractive Cardiovascular and Thoracic Surgery
Volume12
Issue number2
DOIs
Publication statusPublished - 2011

Cite this